ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 671161 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 671161; 2) Community: the network communities that were significantly associated with the response to NSC 671161; 3) Molecule: the relationships between components within communities and NSC 671161; 4) MDR: the compounds that were significantly associated with the NSC 671161.

NSC Compound Enrichment Correlation
NSC 629749 .beta.-Lapachone 0.0385067071027345 -0.075434087
NSC 634766 Null 0.0385067071027345 0.11798058
NSC 638487 (Z) 4-Acetoxy-(3,4',5)-trimethoxystilbene 0.0385067071027345 0.21353407
NSC 639364 2,9-Dimethylellipticinium acetate 0.0385067071027345 0.17734574
NSC 646912 Null 0.0385067071027345 0.10807622
NSC 648365 Insulin-Methotrexate conjugate 0.0385067071027345 0.070656218
NSC 650262 Null 0.0385067071027345 0.22088342
NSC 657751 Null 0.0385067071027345 -0.028250761
NSC 661748 [6,6'-Bibenzo[6,7]cyclohepta[1,2,3-cd]benzofuran]-4,4',8,8', 10,10'-hexol, 1,1',6,6',7,7',11b,11'b-octahydro-1,1',7,7'- tetrakis(4-hydroxyphenyl)-, [1.alpha.,6.beta.(1'R*,6'S*,7'R*),7.alpha]- 0.0385067071027345 -0.10321237
NSC 740644 6-(3-Bromopropyl)-9-ethoxy-5,6-dihydro-3-nitro-5,11-dioxo-11H-indeno[1,2-c]isoquinoline 0.0386895225700407 -0.09186548
Total:61  Current:45    [First] [Prev] [Next] [Last]